Venus Remedies gets European patent for painkiller injection

India's Venus Remedies has been granted a patent by the European Patent Office for its drug Achnil, a once-a-day painkiller injection.

"This novel formulation based on NDDS (Novel Drug Delivery System) technology is going to fill the gap of long standing demand for better pain management therapy," said Venus Remedies Joint Managing Director Manu Chaudhry, in a statement. "Especially for aged population, it is not only going to reduce the number of pricks but will also drastically reduce the side effects associated with the use of NSAIDs."

Venus Remedies plans to commercialize Achnil, which has been developed over the past five years, through out-licensing of exclusive market rights major pharmaceutical companies, the company said in the release. It also said Achnil has completed Phase III clinical trials.

- read the release
- and a report on

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.